Tempus AI (NASDAQ:TEM) Shares Down 4.4% Following Insider Selling

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) was down 4.4% during trading on Friday after an insider sold shares in the company. The stock traded as low as $71.50 and last traded at $73.34. Approximately 5,496,515 shares were traded during trading, a decline of 61% from the average daily volume of 14,108,693 shares. The stock had previously closed at $76.72.

Specifically, CFO James William Rogers sold 31,780 shares of Tempus AI stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $82.33, for a total transaction of $2,616,447.40. Following the sale, the chief financial officer now directly owns 189,320 shares in the company, valued at $15,586,715.60. This trade represents a 14.37 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Erik Phelps sold 61,582 shares of Tempus AI stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $82.36, for a total transaction of $5,071,893.52. Following the sale, the executive vice president now owns 153,080 shares in the company, valued at approximately $12,607,668.80. This represents a 28.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In related news, CAO Ryan M. Bartolucci sold 818 shares of Tempus AI stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $81.87, for a total transaction of $66,969.66. Following the sale, the chief accounting officer now directly owns 46,182 shares in the company, valued at $3,780,920.34. This trade represents a 1.74 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on TEM shares. Loop Capital cut their target price on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a research report on Tuesday, January 14th. Guggenheim assumed coverage on shares of Tempus AI in a research report on Monday, December 9th. They issued a "buy" rating and a $74.00 price target on the stock. William Blair downgraded shares of Tempus AI from an "outperform" rating to a "market perform" rating in a research report on Wednesday, February 12th. TD Cowen restated a "buy" rating and issued a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Finally, Stifel Nicolaus downgraded shares of Tempus AI from a "buy" rating to a "hold" rating and boosted their price target for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $58.55.

Tempus AI Stock Performance

The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The stock's 50-day moving average is $50.29 and its 200-day moving average is $51.65.

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. ARK Investment Management LLC increased its stake in Tempus AI by 132.1% during the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock valued at $186,343,000 after purchasing an additional 3,141,487 shares in the last quarter. NEA Management Company LLC raised its holdings in shares of Tempus AI by 17.8% in the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company's stock valued at $304,846,000 after purchasing an additional 813,169 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Tempus AI by 166.0% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after purchasing an additional 2,021,394 shares during the last quarter. Nikko Asset Management Americas Inc. raised its holdings in shares of Tempus AI by 166.0% in the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after purchasing an additional 2,021,394 shares during the last quarter. Finally, Franklin Resources Inc. raised its holdings in shares of Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock valued at $93,251,000 after purchasing an additional 1,950,862 shares during the last quarter. Institutional investors own 24.22% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.